Health Condition 1: E116- Type 2 diabetes mellitus with other specified complications
Conditions
Interventions
Intervention1: Mesenchymal stimulating peptides: 15 to 20 mg of Mesenchymal stimulating peptide would then be applied daily in the similar fashion for 15 days to 21 days. No dressing would be applied
Sponsors
Dr Mir Sadat Ali
Eligibility
Inclusion criteria
Inclusion criteria: Patients with Chronic nonhealing ulcer (CNU) with Wagner Grades 1 and 2 ulcer size between 2 and 10 cm in the area and ankle brachial index more than 0.75 cm and those who signed an informed consent and consent for follow up of the study duration.
Exclusion criteria
Exclusion criteria: Patients who do not sign the consent Patients who do not fit the inclusion criteria.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Quantitative Healing of the ulcers. 2. Reduction of the size. 3. the treatment will be for 4 weeks.Timepoint: Weekly for 4 weeks. | — |
Secondary
| Measure | Time frame |
|---|---|
| NoneTimepoint: None | — |
Countries
India
Contacts
Public ContactProf Quamar Azam
All India Institute of Medical Science Rishikesh
Outcome results
None listed